Abstract
For patients with a single-positive blood culture growing gram-positive cocci, organism identification can provide supportive information for differentiating contamination from infection. We investigated the effect of a rapid blood culture identification panel (BCID) on vancomycin-prescribing patterns and patient outcomes for single positive blood culture (PBC) growing gram-positive cocci. Adult patients with single-positive blood culture growing gram-positive cocci with conventional organism identification (pre-BCID) were compared with organism identification by BCID (post-BCID). Antimicrobial Stewardship Program (ASP) review of PBC was performed in both study groups. Vancomycin prescribing patterns were studied. Secondary endpoints were the incidence of nephrotoxicity, length of stay (LOS), readmission rate, mortality, and hospital costs. A total of 188 patients (86 pre-BCID, 102 post-BCID) were included. Organism identification was known 21 h sooner in the post-BCID group (P < 0.001). Coagulase-negative staphylococci were the most commonly isolated organisms (73%). In patients where vancomycin was deemed unnecessary (n = 133), vancomycin use (51% pre-BCID vs 36% post-BCID; P = 0.09) and time from culture positivity to vancomycin discontinuation (1.5 vs. 1.7 days; P = 0.92) did not differ between groups. We found no differences in the development of nephrotoxicity, LOS, readmission, mortality, or hospital costs. Earlier identification of single positive blood culture growing gram-positive cocci did not significantly influence prescribing patterns of vancomycin. However, baseline antimicrobial stewardship review of single positive blood culture growing gram-positive cocci may have lessened the opportunity for detectable differences. Larger studies, accounting for the impact of ASP intervention, should be performed to determine the value of each individual component.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Hall KK, Lyman JA (2006) Updated review of blood culture contamination. Clin Microbiol Rev 19(4):788–802
Becker K, Heilmann C, Peters G (2014) Coagulase-negative staphylococci. Clin Microbiol Rev 27(4):870–926
Beekmann SE, Diekema DJ, Doern GV (2005) Determining the clinical significance of coagulase-negative staphylococci isolated from blood cultures. Infect Control Hosp Epidemiol 26(6):559–566
Bekeris LG, Tworek JA, Walsh MK, Valenstein PN (2005) Trends in blood culture contamination: a College of American Pathologists Q-tracks study of 356 institutions. Arch Pathol Lab Med 129(10):1222–1225
Souvenir D, Anderson DE Jr, Palpant S, Mroch H, Askin S, Anderson J et al (1998) Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 36(7):1923–1926
Holland TL, Arnold C, Fowler VG, Jr. Clinical management of Staphylococcus aureus bacteremia: a review. JAMA 2014;312(13):1330–1341
Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE (2017) Association of adverse events with antibiotic use in hospitalized patients. JAMA Intern Med 177(9):1308–1315
Timbrook TT, Morton JB, McConeghy KW, Caffrey AR, Mylonakis E, LaPlante KL (2016) The effect of molecular rapid diagnostic testing on clinical outcomes in bloodstream infections: a systematic review & meta-analysis. Clin Infect Dis
Bauer KA, Perez KK, Forrest GN, Goff DA (2014) Review of rapid diagnostic tests used by antimicrobial stewardship programs. Clin Infect Dis 59(Suppl 3):S134–S145
Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377–381
Blaschke AJ, Heyrend C, Byington CL, Fisher MA, Barker E, Garrone NF et al (2012) Rapid identification of pathogens from positive blood cultures by multiplex polymerase chain reaction using the FilmArray system. Diagn Microbiol Infect Dis 74(4):349–355
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373–383
Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H et al (2004) International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann Intern Med 140(1):26–32
Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P (2004) Acute dialysis quality initiative w. acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 8(4):R204–R212
Alahmadi YM, Aldeyab MA, McElnay JC, Scott MG, Darwish Elhajji FW, Magee FA et al (2011) Clinical and economic impact of contaminated blood cultures within the hospital setting. J Hosp Infect 77(3):233–236
van der Heijden YF, Miller G, Wright PW, Shepherd BE, Daniels TL, Talbot TR (2011) Clinical impact of blood cultures contaminated with coagulase-negative staphylococci at an academic medical center. Infect Control Hosp Epidemiol 32(6):623–625
Buehler SS, Madison B, Snyder SR, Derzon JH, Cornish NE, Saubolle MA et al (2016) Effectiveness of practices to increase timeliness of providing targeted therapy for inpatients with bloodstream infections: a laboratory medicine best practices systematic review and meta-analysis. Clin Microbiol Rev 29:59–103
MacVane SH, Nolte FS (2016) Benefits of adding a rapid PCR-based blood culture identification panel to an established antimicrobial stewardship program. J Clin Microbiol 54(10):2455–2463
Wong JR, Bauer KA, Mangino JE, Goff DA (2012) Antimicrobial stewardship pharmacist interventions for coagulase-negative staphylococci positive blood cultures using rapid polymerase chain reaction. Ann Pharmacother 46:1484–1490
Nagel JL, Huang AM, Kunapuli A, Gandhi TN, Washer LL, Lassiter J et al (2014) Impact of antimicrobial stewardship intervention on coagulase-negative staphylococcus blood cultures in conjunction with rapid diagnostic testing. J Clin Microbiol 52(8):2849–2854
Pardo J, Klinker KP, Borgert SJ, Butler BM, Giglio PG, Rand KH (2016) Clinical and economic impact of antimicrobial stewardship interventions with the FilmArray blood culture identification panel. Diagn Microbiol Infect Dis 84:159–164
Rupp ME, Cavalieri RJ, Marolf C, Lyden E (2017) Reduction in blood culture contamination through use of initial specimen diversion device. Clin Infect Dis
Acknowledgments
We thank the staff of the Medical University of South Carolina Clinical Microbiology Laboratory for their assistance.
Funding
This work was a part of our routine work. No funding was received for this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
SHM is a current employee and shareholder of the Accelerate Diagnostics, Inc. All other authors report no conflicts of interest.
Ethical approval
This study was approved by the local Institutional Review Board (IRB).
Informed consent
A waiver of informed consent was granted by the IRB.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
ESM 1
(PDF 228 kb)
Rights and permissions
About this article
Cite this article
MacVane, S.H., Raux, B.R. & Smith, T.T. Evaluation of rapid polymerase chain reaction-based organism identification of gram-positive cocci for patients with a single positive blood culture. Eur J Clin Microbiol Infect Dis 38, 1471–1479 (2019). https://doi.org/10.1007/s10096-019-03574-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-019-03574-3